Table 79.
Locally acquired human WNV cases (confirmed and probable) and notification rates per 100,000 population in EU MSs and non‐MS countries, by country and year, 2017–2021
| Country | 2021 | 2020 | 2019 | 2018 | 2017 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| National coverage (a) | Data format (a) | Confirmed cases | Total cases* and rates | Total cases* and rates | Total cases* and rates | Total cases* and rates | Total cases* and rates | ||||||
| Cases | Rate | Cases | Rate | Cases | Rate | Cases | Rate | Cases | Rate | ||||
| Austria | Y | C | 3 | 3 | 0.03 | 0 | 0 | 4 | 0.05 | 21 | 0.24 | 6 | 0.07 |
| Belgium | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bulgaria | Y | C | 0 | 0 | 0 | 1 | 0.01 | 5 | 0.07 | 15 | 0.21 | 1 | 0.01 |
| Croatia | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58 | 1.4 | 5 | 0.12 |
| Cyprus | Y | C | 0 | 0 | 0 | 0 | 0 | 23 | 2.6 | 1 | 0.12 | 0 | 0 |
| Czechia | Y | C | 0 | 0 | 0 | 0 | 0 | 1 | 0.01 | 5 | 0.05 | 0 | 0 |
| Denmark (b) | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Estonia | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Finland | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| France | Y | C | 1 (c) | 1(c) | < 0.01 | 0 | 0 | 2 | < 0.01 | 27 | 0.04 | 2 | < 0.01 |
| Germany | Y | C | 4 | 4 | < 0.01 | 22 | 0.03 | 5 | 0.01 | 1 | < 0.01 | – | – |
| Greece (d) | Y | C | 27 | 59 | 0.55 | 144 | 1.3 | 227 | 2.1 | 315 | 2.9 | 48 | 0.45 |
| Hungary | Y | C | 6 | 7 | 0.07 | 3 | 0.03 | 36 | 0.37 | 215 | 2.2 | 20 | 0.20 |
| Ireland | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Italy | Y | C | 65 | 65 | 0.11 | 69 | 0.12 | 54 | 0.09 | 610 | 1.0 | 53 | 0.09 |
| Latvia | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Lithuania | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Luxembourg | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Malta | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netherlands | Y | C | 0 | 0 | 0 | 8 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 |
| Poland | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Portugal | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Romania | Y | C | 6 | 7 | 0.04 | 6 | 0.03 | 67 | 0.35 | 277 | 1.4 | 66 | 0.34 |
| Slovakia | Y | C | 0 | 0 | 0 | 0 | 0 | 1 | 0.02 | 0 | 0 | 0 | 0 |
| Slovenia | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0.19 | 0 | 0 |
| Spain | Y | C | 6 | 6 | 0.01 | 77 | 0.16 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sweden | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EU Total 27 | – | – | 118 | 152 | 0.03 | 330 | 0.07 | 425 | 0.10 | 1.55 | 0.35 | 201 | 0.06 |
| United Kingdom | – | – | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 |
| EU Total (e) | – | – | 118 | 152 | 0.03 | 330 | 0.07 | 425 | 0.08 | 1.55 | 0.31 | 201 | 0.05 |
| Iceland | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Norway | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liechtenstein | Y | C | 0 | 0 | 0 | 1 | 0.01 | 1 | 0.01 | 0 | 0 | 0 | 0 |
| Switzerland (f) | Y | C | 0 | 0 | 0 | ||||||||
–: Data not reported.
: Y: yes; N: no; A: aggregated data; C: case‐based data.
: No surveillance system.
: This case reported by France acquired the WNV infection in Mayotte.
: Only locally acquired cases diagnosed in the country of exposure are included in the table.
: Cases reported by the United Kingdom for the years 2017–2019 were also considered for this estimation (EU‐28). When United Kingdom data were collected for the period 2017–2019, the United Kingdom was an EU MS, but it became a third country on 1 February 2020.
: Switzerland provided data directly to EFSA. The human data for Switzerland include data from Liechtenstein for the years 2017–2020.